Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States

INTRODUCTION: Therapeutic inertia refers to the failure to initiate or intensify treatment in a timely manner and is widespread in type 2 diabetes (T2D) despite the well-established importance of maintaining good glycemic control. The aim of this analysis was to quantify the clinical and economic bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Sarah Naz, Dang-Tan, Tam, Valentine, William J., Hansen, Brian Bekker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004420/
https://www.ncbi.nlm.nih.gov/pubmed/31925649
http://dx.doi.org/10.1007/s12325-019-01199-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004420/
https://www.ncbi.nlm.nih.gov/pubmed/31925649
http://dx.doi.org/10.1007/s12325-019-01199-8

Ejemplares similares